|
1 |
Emerging roles of orphan nuclear receptors in regulation of innate immunity
Jin, Hyo Sun;Kim, Tae Sung;Jo, Eun-Kyeong;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1491-1502,
|
|
2 |
Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance
Yu, Je-Wook;Lee, Myung-Shik;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1503-1518,
|
|
3 |
Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2
Kang, Seok-Seong;Sim, Ju-Ri;Yun, Cheol-Heui;Han, Seung Hyun;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1519-1529,
|
|
4 |
Transcriptional modulation of regulatory T cell development by novel regulators NR4As
Won, Hee Yeon;Hwang, Eun Sook;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1530-1536,
|
|
5 |
Targeting IL-17 in autoimmunity and inflammation
Kim, Byung-Seok;Park, Young-Jun;Chung, Yeonseok;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1537-1547,
|
|
6 |
Essential role of interferon regulatory factor 4 (IRF4) in immune cell development
Nam, Sorim;Lim, Jong-Seok;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1548-1555,
|
|
7 |
Intracellular interleukin (IL)-1 family cytokine processing enzyme
Kwak, Areum;Lee, Youngmin;Kim, Hyunwoo;Kim, Soohyun;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1556-1564,
|
|
8 |
Gut microbiota in autoimmunity: potential for clinical applications
Kim, Donghyun;Yoo, Seung-Ah;Kim, Wan-Uk;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1565-1576,
|
|
9 |
Immune checkpoint inhibitors for cancer treatment
Park, Junsik;Kwon, Minsuk;Shin, Eui-Cheol;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1577-1587,
|
|
10 |
Diverse macrophages polarization in tumor microenvironment
Rhee, Inmoo;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1588-1596,
|
|
11 |
Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer
Ko, Hyun-Jeong;Kim, Yeon-Jeong;
/
The Pharmaceutical Society of Korea
, v.39, no.11, pp.1597-1608,
|
|